UK - Lyceum-backed Synexus acquires ClinPharm

The deal, which is expected to complete in January, will see Lyceum inject fresh capital into the business.

Synexus, based in Lancashire, operates a 26-strong portfolio of research centres in nine countries spanning Western, Central and Eastern Europe, as well as Africa and Asia. The Germany acquisition will increase its total patient population reach to more than 30 million and increase the company's presence in Europe with the addition of 10 further research centres in Germany, Austria and Ukraine.

In November 2007, Lyceum backed the public-to-private of Synexus. The business was delisted from AIM for a cash offer of 78p per share, representing a market capitalisation in excess of £18m. Lyceum funded the deal with equity only at the time, the private equity firm intended to refinance the business at a later date.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland